Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic region

Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic region

Background: There is very little published data on the antibody response to the Vi capsular polysaccharide (Vi-CPS) of S. Typhi during naturally acquired typhoid fever in an endemic area. Methodology: An indirect ELISA, using tyraminated, purified Vi-CPS, was used to assay anti-Vi-CPS antibodies fro...

Full description

Saved in:
Bibliographic Details
Main Authors: Deborah House, Vo A. Ho, To S. Diep, Nguyen T. Chinh, Phan V. Bay, Ha Vinh, Minh Duc, Christopher M. Parry, Gordon Dougan, Nicholas J. White, Jeremy J. Farrar, Tran Tinh Hien, John Wain
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2008-08-01
Series:Journal of Infection in Developing Countries
Subjects:
Vi capsule
Salmonella Typhi
typhoid fever
antibodies
Viet Nam
Vietnam
Online Access:https://jidc.org/index.php/journal/article/view/227
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: There is very little published data on the antibody response to the Vi capsular polysaccharide (Vi-CPS) of S. Typhi during naturally acquired typhoid fever in an endemic area. Methodology: An indirect ELISA, using tyraminated, purified Vi-CPS, was used to assay anti-Vi-CPS antibodies from typhoid fever cases and controls living in the Ho Chi Minh City and Mekong Delta region of Viet Nam. Results: Antibody response to Vi-CPS is significantly higher in typhoid patients who have been ill for more than two weeks than those who are in the first two weeks of illness. The anti-Vi-CPS response is similar for adults and children. Anti-Vi-CPS antibodies can be detected in the sera of non-typhoid patients. The frequency with which this occurs increases with age, probably reflecting increased exposure to S. Typhi. Conclusions: Anti-Vi_CPS is elicited in persons infected with S. Typhi but only after a prolonged duration of illness. Vaccine trials have shown anti-Vi-CPS antibodies to be protective; thus early treatment of typhoid patients, i.e. in the first two week of illness before the Vi-CPS response is elicited, may inhibit the development of this protective immune response.
ISSN:1972-2680

Similar Items